Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Schizophrenia Spectrum Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00654576
What this trial is testing

Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Central South University 1,400
Not applicableStudy completedNCT03800368
What this trial is testing

Exercise and Overnight Motor Sequence Task

Who this might be right for
Schizophrenia and Related DisordersPsychotic Disorders
The University of Hong Kong 51
Testing effectiveness (Phase 2)Study completedNCT01364792
What this trial is testing

To Rescue Cognition With Valaciclovir

Who this might be right for
SchizophreniaPsychosis
University Medical Center Groningen 24
Early research (Phase 1)Ended earlyNCT00364429
What this trial is testing

SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With Schizophrenia

Who this might be right for
Schizophrenia
GlaxoSmithKline 55
Early research (Phase 1)Study completedNCT04252131
What this trial is testing

Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Calo Psychiatric Center 92
Large-scale testing (Phase 3)Study completedNCT00236457
What this trial is testing

A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 629
Large-scale testing (Phase 3)Study completedNCT01192867
What this trial is testing

RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)

Who this might be right for
Schizophrenia
Hoffmann-La Roche 629
Not applicableStudy completedNCT04598906
What this trial is testing

Ecologically Valid Virtual Tasks vs Paper-pencil Methods in Cognitive Rehabilitation in Patients With Schizophrenia and Depression

Who this might be right for
SchizophreniaDepressionCognitive Impairment
National Institute of Mental Health, Czech Republic 35
Not applicableStudy completedNCT02085447
What this trial is testing

A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness

Who this might be right for
Psychotic DisordersSchizophreniaSchizoaffective Disorder+2 more
University Hospitals Cleveland Medical Center 30
Not applicableStudy completedNCT03571685
What this trial is testing

Sustainable Early Episode Clinic Study (SEEC)

Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen Scientific Affairs, LLC 50
Post-approval studies (Phase 4)Study completedNCT00331825
What this trial is testing

Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism

Who this might be right for
SchizophreniaExtrapyramidal Syndrome
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 70
Large-scale testing (Phase 3)Study completedNCT02287584
What this trial is testing

Confirmatory Study of DSP-5423P in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Sumitomo Pharma Co., Ltd. 580
Early research (Phase 1)Study completedNCT02202226
What this trial is testing

Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 96
Post-approval studies (Phase 4)Study completedNCT00231894
What this trial is testing

Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia

Who this might be right for
DiabetesSchizophreniaInsulin Resistance+1 more
Nathan Kline Institute for Psychiatric Research 56
Post-approval studies (Phase 4)Study completedNCT00526877
What this trial is testing

An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment

Who this might be right for
SchizophreniaSchizoaffective Disorders
Johnson & Johnson Taiwan Ltd 31
Large-scale testing (Phase 3)Study completedNCT01104766
What this trial is testing

Safety and Efficacy of Cariprazine in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Forest Laboratories 617
Not applicableEnded earlyNCT06949657
What this trial is testing

Occurrence and Influencing Factors of Cognitive Impairment in Elderly Patients With Schizophrenia and

Who this might be right for
Schizophrenia DisordersCognitive ImpairmentAcceptance and Commitment Therapy
Third People's Hospital, Huzhou City, Zhejiang Province, China 78
Not applicableStudy completedNCT04867681
What this trial is testing

Study of the Impact on the Therapeutic Alliance of a Short Initial Psychoeducation Programme in Patients With Early Schizophrenia

Who this might be right for
Schizophrenia
Centre Hospitalier Universitaire de Nice 21
Not applicableLooking for participantsNCT06005766
What this trial is testing

The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychotic Disorders+2 more
University of Jyvaskyla 85
Large-scale testing (Phase 3)Study completedNCT00641745
What this trial is testing

Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sumitomo Pharma America, Inc. 629
Next Page